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Received February 12, 2015; accepted August 7, 2015AbstractBackground: Group B Streptococcus (GBS) is a leading cause of neonatal morbidity and mortality. In an effort to reduce the impact of this
serious affliction, universal screening for GBS has been adopted in many countries. The objective of this study was to examine the acceptability
of self-collected GBS swabs in a local population in Hong Kong.
Methods: This study is a cross-sectional questionnaire survey conducted in a tertiary teaching hospital. A total of 327 pregnant women who
attended the antenatal clinic for GBS screening from April 2012 to May 2012 were included in our study. The acceptability of GBS self-
screening and its associated factors were analyzed.
Results: Of these women, 200/320 (62.5%) participants preferred screening by healthcare workers, whereas only 18/320 (5.6%) preferred self-
screening. The most common reasons why some participants preferred to be screened by clinicians were that professionals had greater
knowledge, and the added worry about the accuracy of self-screening. 22/320 (69.4%) and 195/320 (60.9%) women believed that they felt
comfortable enough to self-perform the vaginal swab and rectal swab respectively. Previous use of tampons was associated with higher perceived
capability of self-performing the vaginal swab. Perceived capability to self-perform the rectovaginal swabs was associated with a willingness to
self-perform the swabs ( p < 0.001). The majority of women, 303/320 (94.7%), found the current practice of an additional clinic visit for GBS
screening acceptable. However, 218/320 (68.1%) participants would like to undertake self-screening if they were given the chance to do so in the
next pregnancy, and 187/320 (58.4%) would recommend others have self-screening for GBS as well.
Conclusion: Most women in the local population still preferred physician-collected samples for GBS screening, but they welcomed the option of
self-screening in future pregnancies. Improved health education about the importance of GBS screening may improve the willingness of women
to perform self-screening.
Copyright © 2015, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Group B Streptococcus (GBS) is a leading infectious cause
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).maternal gastrointestinal and genital tracts has been found in
10e30% of pregnancies, with vertical transmission being
implicated in early-onset GBS infection in the newborn.2
Since universal screening for GBS was first recommended
by the American College of Obstetricians and Gynecologists
and the Centre for Disease Control and Prevention in 2002,3
the incidence of early-onset GBS has been reduced by 27%
in the United States.4 Universal screening for rectovaginal
GBS colonization at 35e37 weeks is now recommended by
various guidelines from the United States,5 Canada,6
Australia, and New Zealand7 to reduce the morbidity andsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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Hong Kong, 10% of pregnant women are GBS carriers.8 A
universal screening program for GBS for all pregnant women
who attend the Hospital Authority's obstetrics clinics or
Department of Health's Maternal and Child Health Centers
between 35e37 weeks' gestation was launched in January
2012, and intrapartum antibiotics prophylaxis is now given to
screen-positive women.
There is normally no obstetric indication to perform a
vaginal examination outside the scope of GBS screening at
35e37 weeks. In an ideal situation, GBS screening should be
performed during antenatal follow up in the last month of
pregnancy, although it is performed as a separate session in our
unit owing to logistics reasons and busy antenatal clinics.
Universal screening would mean a loss of privacy for the pa-
tient and additional costs in terms of clinic sessions and pro-
fessional expertise in collecting and processing the swabs.
Various studies have shown that patient-collected swabs are at
least as sensitive as those taken by physicians.9e13 These
studies were mainly conducted in western countries, where
self-sampling is common and has been accepted, as is the case
with self-sampling of vaginal secretions for chlamydia. The
adoption of self-screening would depend on the acceptability
of women for self-sampling. If cultural practices do not support
self-sampling of rectovaginal swabs, women may find it diffi-
cult and this may even affect the accuracy of the taken swabs.
There have not been any studies to date comparing the
acceptability and accuracy of self-collected swabs with
clinician-taken swabs in a local population. Although previous
studies suggest that patient-collected swabs are at least as
sensitive as physician-taken swabs, a conservative attitude of
the Chinese culture on self-examination may affect the effi-
cacy of the screening program. However, if self-screening for
GBS is widely acceptable, its implementation can potentially
lead to cost savings. The purpose of the present study is to
examine the acceptability of self-collected GBS swabs in a
local population.
2. Methods
This study was based upon a questionnaire involving
pregnant women attending the antenatal clinic at a tertiary
teaching hospital in Hong Kong for GBS screening. The actual
GBS screening was performed as a separate clinic session at
35e37 weeks' gestation in our unit, and the study was con-
ducted from April 2012 to May, 2012. Approval by the local
Institutional Review Board was obtained, and all participants
gave written informed consent. All women who attended the
clinic for GBS screening and were aged > 18 years were
recruited. The exclusion criteria for this study included: (1)
those with GBS in the midstream urine found at any point
during the pregnancy prior to inclusion into the study; (2) a
history of affected baby such that screening for GBS was not
necessary; or (3) women who could not understand English or
Chinese.
All women who attended the clinic session were given a
visual presentation and an information sheet regardingneonatal GBS infections and GBS screening, including a di-
agram illustrating the relevant anatomy for self-sampling. A
nurse was also available to answer questions from the partic-
ipants. Upon their arrival at the clinic, the participants were
given a questionnaire to complete (Fig. 1), and were asked to
return the questionnaire to the nurse after GBS screening
swabs were taken. The questionnaire included demographic
information, their preference, and acceptability of self-
sampling.
The sample size was calculated based on a 95% confidence
level. One previous study had shown that 28% of women
preferred to perform their own swab, whereas 43% preferred
their physician to perform the swab.11 A sample size of 212
will have a power of 0.9 at 5% significance level to detect such
difference in preference.
In this study, the data was analyzed using SPSS (version 20;
IBM Corporation, New York, USA). The women's preferences
were expressed in percentages, and the Chi-square test and the
Mann-Whitney test were used to examine the factors associ-
ated with their perceived capability to perform self-GBS
screening. A p value < 0.05 was considered statistically
significant.
The primary outcome of this study was the acceptability of
self-collected swabs for GBS screening compared with
clinician-collected swabs.
3. Results
A total of 327 women completed the questionnaire. Of that
number, seven were excluded due to substantial missing data
from the questionnaire (>50% missing values). The mean age
of the participants was 32.1 ± 4.7 years, and the median
gestational age was 35 weeks. The level of education and
occupation of the women who participated in the study are
shown in Table 1.
There were 200/320 (62.5%) participants who preferred
screening by healthcare workers, whereas 102/320 (31.9%)
had no preference, and only 18/320 (5.6%) preferred self-
screening. The reasons for their preference are summarized
in Tables 2 and 3.
We also found that 222/320 (69.4%) and 195/320 (60.9%)
women believed that they were comfortable enough to self-
perform the vaginal swab and rectal swab respectively. Pre-
vious use of tampons was associated with higher perceived
capability of self-performing the vaginal swab (Table 4). None
of the examined factors was associated with the perceived
capability of self-performing the rectal swab (Table 5).
Perceived capability to self-perform the vaginal and rectal
swabs was associated with a willingness to self-perform the
swabs ( p < 0.001; Table 6).
The majority of women (303/320, 94.7%) found the
current practice of an additional clinic visit for GBS
screening acceptable. Nevertheless, 218/320 (68.1%) par-
ticipants would like to undertake self-screening if they were
given the chance to do so in the next pregnancy, and 187/320
(58.4%) would recommend others to have self-screening for
GBS.
Study Title:A questionnaire study on the acceptability of self sampling versus 
screening by clinician for Group B streptococcus
Part 1 background information
1. Age: _____________
2. Current gestation: _____________
3. Occupation: _____________
4. Education level: Primary Secondary Tertiary and above
5. Religion: No Yes, please specify _______
6. No. of pregnancies in the past: 0 1 2 3 >3
7. Do you smoke? Yes No
8. Do you drink alcohol? Yes No
9. Do you have history of GBS affected baby? Yes No
Part 2 preference and acceptability of self sampling
1. Have you had any cervical smear before? Yes No
If yes, how many times have you had such screening? 1 2 3 >3
2. Have you ever used any vaginal suppositories e.g. for candida infection?
Yes No
If yes, how many times? 1 2 3 >3
3. Have you used tampons before? Yes No
If yes, how many times? 1 2 3 >3
4. Have you used an intrauterine device for contraception before? Yes No
If yes, have you ever performed self checking of the IUCD thread? Yes No
5. Have you heard of GBS infection in the past? Yes No
6. Have you had rectovaginal swab taken for GBS screening in the past?
Yes No
7. Do you feel that the current practice (i.e. an extra visit to the clinic just for GBS 
sampling) is acceptable? Yes No
8. If you were given a choice to perform the rectovaginal swab yourself, do you feel 
comfortable in doing it after being given information on it? 
Yes No
9. Will you prefer the swab to be taken by the doctor?
Yes No No preference
If Yes, why:
- Professional had greater knowledge
- Worry about accuracy of result
- Difficult to perform self sampling
- Dislike the self-test
- Others: (please state)
If No, why:
- More Privacy
- No need for extra clinic visit
- Greater physical comfort
- Easy to perform
- Desire for knowledge about own body
- Desire for knowledge about performing the test
- Others: (please state)
10.Will you want to have self-screening in your next pregnancy if you were given a 
chance to do so? Yes No
11.Would you recommend others to have self GBS screening?  Yes No
12.Any other comments:
End of this questionnaire
Fig. 1. Participant questionnaire. GBS ¼ Group B Streptococcus; IUCD ¼ intrauterine contraceptive device.
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Table 1
Occupation and education level of participants.
No. of participants %
Occupation Housewife 55/274 20.1
Manual worker 4/274 1.4
Professional 42/274 15.3
Sedentary work 146/274 53.3
Unemployed 24/274 8.8
Others 3/274 1.1
Education Primary 5/312 1.6
Secondary 124/312 39.7
Tertiary 183/312 58.7
Table 2
Reasons for preferring clinician collection of swabs.
Reason No. of participants %
Professionals have greater knowledge 121/200 60.5
Worry about the accuracy of results 113/200 56.5
Difficult to perform self-sampling 57/200 28.5
Dislike the self-test 11/200 5.5
Others 1/200 0.5
Table 3
Reasons for preferring self-collection.
Reason No. of
participants
%
More privacy 9/18 50.0
No need for extra clinic visit 18/18 100.0
Greater physical comfort 9/18 50.0
Easy to perform 7/18 38.9
Desire for knowledge about own body 1/18 5.6
Desire for knowledge about performing the test 3/18 16.7
Table 4
Factors associated with perceived ability to self-perform vaginal screening.
Perceived capability of self-
performing vaginal screening
p
Yes No
Age (y) 32.1 ± 4.6 32.3 ± 4.7 0.508
Education
e primary 2/217 (0.9) 3/95 (3.2) 0.357
e secondary 83/217 (38.2) 41/95 (43.2)
e tertiary 132/217 (60.8) 51/95 (53.7)
Previous delivery 80/220 (36.4) 40/96 (41.7) 0.380
Previous cervical smear 155/221 (70.1) 74/96 (77.1) 0.222
Use of vaginal pessary 82/222 (36.9) 32/97 (33.0) 0.528
Tampon use 90/221 (40.7) 24/94 (25.5) 0.011
History of IUCD use 5/220 (2.3) 3/95 (3.2) 0.701
Self-check IUCD thread 1/4 (25) 1/3 (33.3) > 0.999
Data are presented as n (%) unless otherwise indicated.
IUCD ¼ intrauterine contraceptive device.
Table 5
Factors associated with perceived ability to self-perform rectal screening.
Perceived capability of self-
performing rectal screening
p
Yes No
Age (y) 32.3 ± 4.6 32.1 ± 4.8 0.887
Education
e primary 2/190 (1.1) 3/119 (2.5) 0.397
e secondary 69/190 (36.3) 52/119 (43.7)
e tertiary 119/190 (62.6) 64/119 (53.8)
Previous delivery 74/193(38.3) 45/121 (37.2) 0.905
Previous cervical smear 139/194 (71.6) 89/121 (73.6) 0.796
Use of vaginal pessary 68/195 (34.9) 47/122 (38.5) 0.549
Tampon use 77/194 (39.7) 37/119 (31.1) 0.147
History of IUCD use 5/193 (2.6) 3/120 (2.5) > 0.999
Self-check IUCD thread 1/4 (25) 1/3 (33.3) > 0.999
Data are presented as n (%) unless otherwise indicated.
IUCD ¼ intrauterine contraceptive device.
Table 6
Relationship between perceived capability to self-perform the rectovaginal
swabs and willingness to self-perform the swabs.
Perceived capability Willingness to self-perform swabs p
Yes No
Vaginal swab 175/217 (80.6) 43/97 (44.3) < 0.001
Rectal swab 158/217 (72.8) 33/95 (34.7) < 0.001
Data are presented as n (%) unless otherwise indicated.
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The current available literature on GBS self-screening
suggests that, in fact, a majority of women prefer self-
screening,9,12,13 and the accuracy of self-screening has been
proven in several studies.9e13 In some countries, self-screening is now a well-accepted practice, and resources that
provide information about self-collection of genital swabs are
available online.5,7,14 Our study is the first investigation that
examines the attitudes of women on GBS self-screening in a
local population in Hong Kong. In contrast to existing studies,
most women in our study preferred physician collection of
samples rather than self-screening. However, this finding is not
surprising given cultural differences. Unfortunately, ethnicity
was not looked into specifically; although, it can be assumed
that >80% of our patients were Chinese based on our
departmental annual statistics.
Several factors that could affect a woman's view of self-
screening were studied. The use of tampons is by far less
common in Hong Kong than in western countries, and is the
only factor associated with a perceived capability of taking a
low vaginal swab and therefore self-screening. Furthermore,
self-screening would involve taking a rectal swab, however,
none of the examined factors were associated with a perceived
capability of self-performing a rectal swab. Providing more
information or having a dedicated nurse to explain GBS
screening to the participants could have increased the pro-
portion of women who would opt for self-screening, although
this was not specifically studied. However, it was of particular
interest that although most of our participants preferred
clinician screening, a majority of them indicated they would
like to try self-screening in their next pregnancy and would
recommend self-screening to others. It is possible that the
participants felt that they were capable of self-screening after
87J.K.Y. Ko et al. / Journal of the Chinese Medical Association 79 (2016) 83e87their experience with this study. However, further studies are
needed to determine if this ‘contradictory’ finding is genuine
or merely a misinterpretation of the wording in the question-
naire by the participants.
Price et al9 suggested that less-educated women might be
more reluctant to collect their own samples. Nevertheless,
Hicks and Diaz-Perez10 demonstrated that the accuracy of
GBS self-screening was not affected among patients with
limited education who were given minimal information about
the collection technique. Most of the women in our study had
at least secondary or tertiary qualifications and >50% were
confident that they could take the vaginal and rectal swabs
themselves. In the study by Law et al,14 the clinician-obtained
swabs caused mild to moderate pain in 68% of women and
severe pain in 5% of women, in contrast to the self-sampled
population where a majority of women described minimal
pain and found the procedure acceptable. With an increasing
amount of health information available, women are likely to
wish to take an active role in healthcare and self-screening that
would provide such autonomy. The next question that needs to
be answered would be the accuracy and cost effectiveness of
self-screening in the local population, which was not exam-
ined in our study. A larger and longer-period study involving
multiple centers should also be performed to provide more
information on this aspect.
In conclusion, most women in the local population still
preferred physician-collected samples for GBS screening,
however, they welcomed the option of self-screening in future
pregnancies. Further studies that focus on the accuracy of self-
screening and cost analysis are needed for GBS self-screening
to be implemented.
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